No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects - Lerche, S; Soendergaard, L; Rungby, J (Clin Endocrinol (Oxf), 2009)
et al.